CARDIOVASCULAR THERAPY AND PREVENTION,
Journal Year:
2023,
Volume and Issue:
22(11), P. 3711 - 3711
Published: Dec. 10, 2023
Aim.
To
analyze
the
metabolomic
profile
of
patients
with
coronavirus
disease
2019
(COVID-19)
using
mass
spectrometry
methods
and
taking
into
account
clinical
laboratory
history.
Studying
relationship
between
severity
COVID-19
symptoms
concentration
primary
metabolites,
primarily
amino
acids.
Material
.
The
retrospective
study
included
serum
samples
from
a
total
935
people
(445
men
490
women)
collection
biobank
City
Hospital
№
40.
A
was
studied
in
all
chromatography-mass
spectrometry.
R
language
used
for
statistical
data
processing.
Results.
Based
on
analysis,
difference
metabolic
identified
depending
—
52
84
detected
compounds,
differences
were
observed
significance
p<0,01.
Significant
recorded
organic
acids,
acids
their
derivatives.
Conclusion.
Using
collection,
biomaterial
hospitalized
diagnosis
carried
out.
According
to
results
obtained,
kynurenine,
phenylalanine
acetylcarnitine
are
associated
severity.
Differences
cytokine
storm
at
time
blood
collection.
Potential
biomarkers
identified.
Mechanisms of Ageing and Development,
Journal Year:
2023,
Volume and Issue:
211, P. 111792 - 111792
Published: Feb. 17, 2023
Geroscience
puts
mechanisms
of
aging
as
a
driver
the
most
common
age-related
diseases
and
dysfunctions.
Under
this
perspective,
addressing
basic
will
produce
better
understanding
than
each
disease
pathophysiology
individually.
Worldwide,
despite
greater
functional
impairment,
life
expectancy
is
higher
in
women
men.
Gender
differences
prevalence
multimorbidity
lead
mandatory
to
underlying
gender-related
patterns
disability-free
expectancy.
Extensive
literature
suggested
that
inflammaging
at
crossroad
diseases.
In
review,
we
highlight
main
evidence
on
sex/gender
foster
inflammaging,
i.e.
age-dependent
triggering
innate
immunity,
modifications
adaptive
accrual
senescent
cells,
underpinning
some
biomarkers
show
sex-related
differences.
framework
"gender
medicine
perspective",
also
discuss
how
can
affect
sex
COVID-19
severe
outcomes.
Frontiers in Molecular Biosciences,
Journal Year:
2023,
Volume and Issue:
10
Published: Feb. 15, 2023
COVID-19
currently
represents
one
of
the
major
health
challenges
worldwide.
Albeit
its
infectious
character,
with
onset
affectation
mainly
at
respiratory
track,
it
is
clear
that
pathophysiology
has
a
systemic
ultimately
affecting
many
organs.
This
feature
enables
possibility
investigating
SARS-CoV-2
infection
using
multi-omic
techniques,
including
metabolomic
studies
by
chromatography
coupled
to
mass
spectrometry
or
nuclear
magnetic
resonance
(NMR)
spectroscopy.
Here
we
review
extensive
literature
on
metabolomics
in
COVID-19,
unraveled
aspects
disease
including:
characteristic
metabotipic
signature
associated
discrimination
patients
according
severity,
effect
drugs
and
vaccination
treatments
characterization
natural
history
metabolic
evolution
disease,
from
full
recovery
long-term
long
sequelae
COVID.
Frontiers in Immunology,
Journal Year:
2023,
Volume and Issue:
14
Published: May 9, 2023
Background
Deep
metabolomic,
proteomic
and
immunologic
phenotyping
of
patients
suffering
from
an
infection
with
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
have
matched
a
wide
diversity
clinical
symptoms
potential
biomarkers
for
disease
2019
(COVID-19).
Several
studies
described
the
role
small
as
well
complex
molecules
such
metabolites,
cytokines,
chemokines
lipoproteins
during
in
recovered
patients.
In
fact,
after
SARS-CoV-2
viral
almost
10-20%
experience
persistent
post
12
weeks
recovery
defined
long-term
COVID-19
(LTCS)
or
long
post-acute
(PACS).
Emerging
evidence
revealed
that
dysregulated
immune
system
persisting
inflammation
could
be
one
key
drivers
LTCS.
However,
how
these
biomolecules
altogether
govern
pathophysiology
is
largely
underexplored.
Thus,
clear
understanding
parameters
within
integrated
fashion
predict
course
would
help
to
stratify
LTCS
This
even
allow
elucidation
mechanistic
course.
Methods
study
comprised
subjects
(n=7;
longitudinal),
(n=33),
Recov
(n=12),
no
history
positive
testing
(n=73).
1
H-NMR-based
metabolomics
IVDr
standard
operating
procedures
verified
phenotyped
all
blood
samples
by
quantifying
38
metabolites
112
lipoprotein
properties.
Univariate
multivariate
statistics
identified
NMR-based
cytokine
changes.
Results
Here,
we
report
on
analysis
serum/plasma
NMR
spectroscopy
flow
cytometry-based
cytokines/chemokines
quantification
We
lactate
pyruvate
were
significantly
different
either
healthy
controls
(HC)
Subsequently,
correlation
group
only
among
cytokines
amino
acids
histidine
glutamine
uniquely
attributed
mainly
pro-inflammatory
cytokines.
Of
note,
triglycerides
several
(apolipoproteins
Apo-A1
A2)
demonstrate
COVID-19-like
alterations
compared
HC.
Interestingly,
distinguished
mostly
their
phenylalanine,
3-hydroxybutyrate
(3-HB)
glucose
concentrations,
illustrating
imbalanced
energy
metabolism.
Most
present
at
low
levels
HC
except
IL-18
chemokine,
which
tended
higher
Conclusion
The
identification
plasma
will
better
other
diseases
ongoing
severity
npj Biofilms and Microbiomes,
Journal Year:
2024,
Volume and Issue:
10(1)
Published: Aug. 1, 2024
Abstract
The
clinical
course
of
COVID-19
is
variable
and
often
unpredictable.
To
test
the
hypothesis
that
disease
progression
inflammatory
responses
associate
with
alterations
in
microbiome
metabolome,
we
analyzed
metagenome,
cytokine,
transcriptome
profiles
repeated
samples
from
hospitalized
patients
uninfected
controls,
leveraged
information
post-hoc
confounder
analysis.
Severe
was
associated
a
depletion
beneficial
intestinal
microbes,
whereas
oropharyngeal
microbiota
disturbance
mainly
linked
to
antibiotic
use.
severity
also
enhanced
plasma
concentrations
kynurenine
reduced
levels
several
other
tryptophan
metabolites,
lysophosphatidylcholines,
secondary
bile
acids.
Moreover,
various
metabolites
were
Faecalibacterium
,
decrease
increase
production
cytokines.
Collectively,
our
study
identifies
correlated
metabolome
as
potential
contributor
dysregulation
severe
COVID-19.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(16), P. 9082 - 9082
Published: Aug. 21, 2024
Kynurenic
acid
(KYNA)
is
an
antioxidant
degradation
product
of
tryptophan
that
has
been
shown
to
have
a
variety
cytoprotective,
neuroprotective
and
neuronal
signalling
properties.
However,
mammalian
transporters
receptors
display
micromolar
binding
constants;
these
are
consistent
with
its
typically
tissue
concentrations
but
far
above
serum/plasma
concentration
(normally
tens
nanomolar),
suggesting
large
gaps
in
our
knowledge
transport
mechanisms
action,
the
main
influx
characterized
date
equilibrative,
not
concentrative.
In
addition,
it
substrate
known
anion
efflux
pump
(ABCC4),
whose
vivo
activity
largely
unknown.
Exogeneous
addition
L-tryptophan
or
L-kynurenine
leads
production
KYNA
also
many
other
co-metabolites
(including
some
such
as
3-hydroxy-L-kynurenine
quinolinic
may
be
toxic).
With
exception
chestnut
honey,
exists
at
relatively
low
levels
natural
foodstuffs.
bioavailability
reasonable,
terminal
element
irreversible
reaction
most
pathways,
might
added
exogenously
without
disturbing
upstream
metabolism
significantly.
Many
examples,
which
we
review,
show
valuable
bioactivity.
Given
above,
review
potential
utility
nutraceutical,
finding
significantly
worthy
further
study
development.
Scientific Reports,
Journal Year:
2025,
Volume and Issue:
15(1)
Published: Feb. 24, 2025
The
clinical
manifestations
of
the
cytokine
storm
(CS)
associated
with
COVID-19
resemble
acute
phase
sepsis.
Metabolomics
may
contribute
to
understanding
specific
pathobiology
these
two
syndromes.
aim
this
study
was
compare
serum
metabolomic
profiles
in
CS
vs.
septic
surgery
patients.
In
a
retrospective
cross-sectional
study,
samples
from
patients
COVID-19,
and
without
comorbidity,
as
well
surgical
sepsis
were
investigated.
Targeted
analysis
performed
on
all
using
LC–MS/MS.
Analysis
revealed
that
similar
alterations
metabolome
amino
acid
metabolism,
nitrogen
inflammatory
status,
methionine
cycle
glycolysis.
most
significant
difference
found
for
levels
metabolites
kynurenine
synthesis,
tricarboxylic
cycle,
gamma-aminobutyric
niacinamide.
metabolic
pathway
cysteine
metabolism
significantly
disturbed
For
first
time,
similarities
differences
between
investigated
Northwest
Russian
Federation.
Journal of Global Health,
Journal Year:
2025,
Volume and Issue:
15
Published: Feb. 28, 2025
Despite
advances
in
metabolomic
research
on
COVID-19,
existing
studies
have
small
sample
sizes
and
few
comprehensively
described
the
metabolic
characteristics
of
patients
with
COVID-19
at
each
stage.
In
this
systematic
review,
we
aimed
to
summarise
similarities
differences
biomarkers
different
severity
describe
their
stages.
We
retrieved
from
PubMed,
Embase,
Web
Science,
Cochrane
Library
published
by
October
2022.
performed
a
meta-analysis
untargeted
targeted
metabolomics
data,
using
ratio
means
as
effect
size.
compared
changes
metabolite
levels
between
varying
controls
investigated
sources
heterogeneity
through
subgroup
analyses
meta-regression
analysis.
included
22
cohorts
21
studies,
comprising
2421
participants,
including
healthy
controls.
conducted
analysis
1058
metabolites
study.
The
results
indicated
that,
control
group,
23
were
associated
mild
cases
(P
<
0.05),
3
moderate
37
severe
0.05).
Pathway
enrichment
revealed
significant
disturbances
amino
acid
metabolism,
aminoacyl-tRNA
biosynthesis,
primary
bile
pantothenate
CoA
tricarboxylic
cycle,
taurine
hypotaurine
nitrogen
metabolism
mild,
moderate,
disease.
Additionally,
found
that
stage
exhibited
unique
patterns
(all
P
0.05)
degree
dysregulation
progressively
worsened
increasing
disease
our
indicate
thereby
providing
new
pathways
for
study
pathogenesis,
development
precise
treatment,
formulation
comprehensive
strategies.
PROSPERO:
CRD42022369937.
Turkish Journal of Biochemistry,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 26, 2025
Abstract
Objectives
The
Pasteur
effect
in
cellular
energy
metabolism
is
defined
as
the
switch
to
anaerobic
glycolysis
due
alterations
ambient
oxygen
concentration
or
inhibition
of
electron
transport
chain
(ETC)
and
oxidative
phosphorylation.
This
study
aimed
determine
Severe
Acute
Respiratory
Syndrome
Coronavirus
2
(SARS-CoV-2)
infection
on
leukocytes
among
Disease
2019
(COVID-19)
patients
at
various
stages.
Methods
A
total
90
cases
were
analyzed
asymptomatic,
mild,
moderate,
severe
COVID-19
patients.
Levels
aerobic
intermediates
products
measured
with
liquid
chromatography-tandem
mass
spectrometry
(LC-MS/MS)
analysis.
Results
decrease
rate
was
found
disease
progressed
(p-values<0.001),
while
unchanged
all
groups
because
lactate
levels
had
no
difference
between
(p=0.754).
Moreover,
ratios
Tricarboxylic
Acid
(TCA)
cycle
parameters
demonstrated
a
significant
reduction
different
stages
(p-values<0.001).
Furthermore,
Receiver
Operating
Characteristic
(ROC)
curve
analysis
for
citrate,
alpha-ketoglutarate,
fumarate,
lactate,
lactate/citrate,
lactate/alpha-ketoglutarate,
lactate/fumarate
cut-off
values
Moderate
(p<0.001).
Conclusions
Our
results
suggest
that
from
shown
be
induced
severity
progresses.
Journal of Proteome Research,
Journal Year:
2025,
Volume and Issue:
unknown
Published: May 19, 2025
In
the
present
study,
we
investigated
biochemical,
hematological,
lipidomic,
and
metabolomic
alterations
associated
with
different
SAR-CoV-2
variants
of
concern
(VOCs),
such
as
WT,
α,
β,
γ,
δ,
well
their
impact
on
COVID-19
severity.
Across
first
second
waves
in
India,
a
machine
learning
approach
was
used
3134
patients,
nine
critical
biochemical
hematological
parameters,
namely,
C-reactive
protein
(CRP),
D-dimer,
ferritin,
neutrophil,
WBC
count,
lymphocyte,
urea,
creatine,
lactate
dehydrogenase
(LDH),
were
identified.
Furthermore,
through
metabolic
lipidomic
profiles
lung
colon
cells
transfected
spike
VOCs,
notable
dysregulation
exhibited
by
delta
variant
correlated
characteristic
pathways
catecholamine
thyroid
hormone
synthesis.
A
corroborating
meta-analysis
also
highlighted
involvement
urea
amino
acid
metabolism
pathways.
Overall,
our
study
provides
crucial
insights
into
disruptions
caused
contributing
to
better
understanding
pathogenesis
development
targeted
interventions.
Neurology Genetics,
Journal Year:
2024,
Volume and Issue:
10(2)
Published: March 25, 2024
Thymidine
kinase
2
deficiency
(TK2d)
is
a
rare
autosomal
recessive
disorder
that
stems
from
perturbation
of
the
mitochondrial
DNA
maintenance.
Nucleoside
treatment
has
recently
shown
promise
as
disease-modifying
therapy.
TK2d
was
initially
associated
with
rapidly
progressive
fatal
myopathy
in
children
featuring
depletion.
Subsequently,
less
severe
variants
disease
were
described,
onset
symptoms
during
adolescence
or
adulthood
and
presence
multiple
mtDNA
deletions.
These
phenotypes
have
been
reported
only
15%
approximately
120
patients
described
worldwide.
However,
some
reports
suggest
these
juvenile
adult-onset
presentations
may
be
more
common.
The
objective
this
study
to
describe
clinical
phenotype
sample
Spain.